Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension
M Testa,
M Yeh,
P Lee,
R Fanelli,
F Loperfido,
JW Berman,
and
TH LeJemtel
Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
OBJECTIVES: This study sought to determine the circulating levels of cytokines and their respective endogenous modulators in patients with congestive heart failure of variable severity. BACKGROUND: Activation of immune elements localized in the heart or periphery, or both, may promote release of cytokines in patients with congestive heart failure. Although an increased circulating level of tumor necrosis factor-alpha (TNF-alpha) and its soluble receptor type II (sTNF-RII) is well documented, less is known about other cytokines (i.e., interleukin-1-beta [IL-1-beta], interleukin-6 [IL-6] and interleukin-2 [IL-2] and their soluble receptor/receptor antagonists). METHODS: Circulating levels of TNF-alpha and sTNF-RII, IL-1-beta, IL-1 receptor antagonist (IL-1-Ra), IL-6, IL-6 soluble receptor (IL-6-sR), IL-2 and IL-2 soluble receptor-alpha were measured using enzyme-linked immunosorbent assay kits (Quantikine, R&D Systems) in 80 patients with congestive heart failure due to coronary artery disease or hypertension. The severity of their symptoms, which ranged from New York Heart Association functional class I to IV, was confirmed by measurement of peak oxygen consumption. RESULTS: The percentage of patients with elevated levels of cytokines and their corresponding soluble receptor/receptor antagonists significantly increased with functional class. For TNF-alpha and IL-1-beta, the percentage of patients with elevated levels of soluble receptor/receptor antagonists was higher than that of patients with elevated levels of the cytokine itself. For IL-6, the percentage of patients with elevated levels of IL-6-sR tended to be lower than that of patients with elevated levels of IL-6. All but two patients had undetectable levels of IL-2, and all but seven had levels of IL-2-sR within a normal range. CONCLUSIONS: In patients with congestive heart failure, circulating levels of cytokines increased with the severity of symptoms. In these patients, circulating levels of sTNF-RII and IL-1-Ra are more sensitive markers of immune activation than are circulating levels of TNF-alpha and IL-1-beta, respectively. Levels of IL-2 and IL-2-sR are not elevated when congestive heart failure is due to coronary artery disease or hypertension.
This article has been cited by other articles:

|
 |

|
 |
 
H. Bahrami, D. A. Bluemke, R. Kronmal, A. G. Bertoni, D. M. Lloyd-Jones, E. Shahar, M. Szklo, and J. A.C. Lima
Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study.
J. Am. Coll. Cardiol.,
May 6, 2008;
51(18):
1775 - 1783.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Vellaichamy, D. Zhao, N. Somanna, and K. N. Pandey
Genetic disruption of guanylyl cyclase/natriuretic peptide receptor-A upregulates ACE and AT1 receptor gene expression and signaling: role in cardiac hypertrophy
Physiol Genomics,
October 19, 2007;
31(2):
193 - 202.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Andrei, R. Fraguas Jr., R. M.S. Telles, T. C.T.F. Alves, C. M.C. Strunz, A. Nussbacher, J. Rays, D. V. Iosifescu, and M. Wajngarten
Major Depressive Disorder and Inflammatory Markers in Elderly Patients With Heart Failure
Psychosomatics,
August 1, 2007;
48(4):
319 - 324.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Merkle, S. Frantz, M. P. Schon, J. Bauersachs, M. Buitrago, R. J.A. Frost, E. M. Schmitteckert, M. J. Lohse, and S. Engelhardt
A Role for Caspase-1 in Heart Failure
Circ. Res.,
March 16, 2007;
100(5):
645 - 653.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. H. Le Jemtel, M. Padeletti, and S. Jelic
Diagnostic and Therapeutic Challenges in Patients With Coexistent Chronic Obstructive Pulmonary Disease and Chronic Heart Failure
J. Am. Coll. Cardiol.,
January 16, 2007;
49(2):
171 - 180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Adams, A. Linke, U. Wisloff, C. Doring, S. Erbs, N. Krankel, C. C. Witt, S. Labeit, U. Muller-Werdan, G. Schuler, et al.
Myocardial expression of Murf-1 and MAFbx after induction of chronic heart failure: Effect on myocardial contractility
Cardiovasc Res,
January 1, 2007;
73(1):
120 - 129.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. Mazzadi, X. Andre-Fouet, N. Costes, P. Croisille, D. Revel, and M. F. Janier
Mechanisms leading to reversible mechanical dysfunction in severe CAD: alternatives to myocardial stunning
Am J Physiol Heart Circ Physiol,
December 1, 2006;
291(6):
H2570 - H2582.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. R. van Kimmenade, J. L. Januzzi Jr, P. T. Ellinor, U. C. Sharma, J. A. Bakker, A. F. Low, A. Martinez, H. J. Crijns, C. A. MacRae, P. P. Menheere, et al.
Utility of Amino-Terminal Pro-Brain Natriuretic Peptide, Galectin-3, and Apelin for the Evaluation of Patients With Acute Heart Failure
J. Am. Coll. Cardiol.,
September 19, 2006;
48(6):
1217 - 1224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Li, G. Takemura, H. Okada, S. Miyata, R. Maruyama, L. Li, M. Higuchi, S. Minatoguchi, T. Fujiwara, and H. Fujiwara
Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure
Cardiovasc Res,
September 1, 2006;
71(4):
684 - 694.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. C. Mehra, V. S. Ramgolam, and J. R. Bender
Cytokines and cardiovascular disease
J. Leukoc. Biol.,
October 1, 2005;
78(4):
805 - 818.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Toth, D. E. Matthews, P. A. Ades, M. D. Tischler, P. Van Buren, M. Previs, and M. M. LeWinter
Skeletal muscle myofibrillar protein metabolism in heart failure: relationship to immune activation and functional capacity
Am J Physiol Endocrinol Metab,
April 1, 2005;
288(4):
E685 - E692.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. C. Colombo, J. E. Banchs, S. Celaj, A. Talreja, J. Lachmann, S. Malla, N. B. DuBois, A. W. Ashton, F. Latif, U. P. Jorde, et al.
Endothelial Cell Activation in Patients With Decompensated Heart Failure
Circulation,
January 4, 2005;
111(1):
58 - 62.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Yang, R. Zheng, S. Hu, Y. Ma, M. A. Choudhry, J. L. Messina, L. W. Rue III, K. I. Bland, and I. H. Chaudry
Mechanism of cardiac depression after trauma-hemorrhage: increased cardiomyocyte IL-6 and effect of sex steroids on IL-6 regulation and cardiac function
Am J Physiol Heart Circ Physiol,
November 1, 2004;
287(5):
H2183 - H2191.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Morley and R. N. Baumgartner
Cytokine-Related Aging Process
J. Gerontol. A Biol. Sci. Med. Sci.,
September 1, 2004;
59(9):
M924 - M929.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Langer, R. Schramm, M. Bauer, D. Tscholl, T. Kunihara, and H.-J. Schafers
Cytokine Response to Pulmonary Thromboendarterectomy
Chest,
July 1, 2004;
126(1):
135 - 141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Jortani, S. D. Prabhu, and R. Valdes Jr
Strategies for Developing Biomarkers of Heart Failure
Clin. Chem.,
February 1, 2004;
50(2):
265 - 278.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. L. Yang, R. Gros, M. G. Kabir, A. Sadi, A. I. Gotlieb, M. Husain, and D. J. Stewart
Conditional Cardiac Overexpression of Endothelin-1 Induces Inflammation and Dilated Cardiomyopathy in Mice
Circulation,
January 20, 2004;
109(2):
255 - 261.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.R. Keys and W.J. Koch
The Adrenergic Pathway and Heart Failure
Recent Prog. Horm. Res.,
January 1, 2004;
59(1):
13 - 30.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. A. Ahokas, K. J. Warrington, I. C. Gerling, Y. Sun, L. A. Wodi, P. A. Herring, L. Lu, S. K. Bhattacharya, A. E. Postlethwaite, and K. T. Weber
Aldosteronism and Peripheral Blood Mononuclear Cell Activation: A Neuroendocrine-Immune Interface
Circ. Res.,
November 14, 2003;
93
(10):
e124 - e135.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Gielen, V. Adams, S. Mobius-Winkler, A. Linke, S. Erbs, J. Yu, W. Kempf, A. Schubert, G. Schuler, and R. Hambrecht
Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure
J. Am. Coll. Cardiol.,
September 3, 2003;
42(5):
861 - 868.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Aker, S. Belosjorow, I. Konietzka, A. Duschin, C. Martin, G. Heusch, and R. Schulz
Serum but not myocardial TNF-{alpha} concentration is increased in pacing-induced heart failure in rabbits
Am J Physiol Regulatory Integrative Comp Physiol,
August 1, 2003;
285(2):
R463 - R469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. C. Gerling, Y. Sun, R. A. Ahokas, L. A. Wodi, S. K. Bhattacharya, K. J. Warrington, A. E. Postlethwaite, and K. T. Weber
Aldosteronism: an immunostimulatory state precedes proinflammatory/fibrogenic cardiac phenotype
Am J Physiol Heart Circ Physiol,
July 11, 2003;
285(2):
H813 - H821.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Vasan, L. M. Sullivan, R. Roubenoff, C. A. Dinarello, T. Harris, E. J. Benjamin, D. B. Sawyer, D. Levy, P. W.F. Wilson, and R. B. D'Agostino
Inflammatory Markers and Risk of Heart Failure in Elderly Subjects Without Prior Myocardial Infarction: The Framingham Heart Study
Circulation,
March 25, 2003;
107(11):
1486 - 1491.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. A. Malave, A. A. Taylor, J. Nattama, A. Deswal, and D. L. Mann
Circulating Levels of Tumor Necrosis Factor Correlate With Indexes of Depressed Heart Rate Variability: A Study in Patients With Mild-to-Moderate Heart Failure
Chest,
March 1, 2003;
123(3):
716 - 724.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P A Henriksen and D E Newby
Therapeutic inhibition of tumour necrosis factor {alpha} in patients with heart failure: cooling an inflamed heart
Heart,
January 1, 2003;
89(1):
14 - 18.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Sun, J. Zhang, L. Lu, S. S. Chen, M. T. Quinn, and K. T. Weber
Aldosterone-Induced Inflammation in the Rat Heart : Role of Oxidative Stress
Am. J. Pathol.,
November 1, 2002;
161(5):
1773 - 1781.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Keys, E. A. Greene, W. J. Koch, and A. D. Eckhart
Gq-Coupled Receptor Agonists Mediate Cardiac Hypertrophy Via the Vasculature
Hypertension,
November 1, 2002;
40(5):
660 - 666.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Saito, F. Hu, L. Tayara, L. Fahas, H. Shennib, and A. Giaid
Inhibition of NOS II prevents cardiac dysfunction in myocardial infarction and congestive heart failure
Am J Physiol Heart Circ Physiol,
July 1, 2002;
283(1):
H339 - H345.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Plenz, H. Eschert, M. Erren, T. Wichter, M. Bohm, M. Flesch, H. H. Scheld, and M. C. Deng
The interleukin-6/interleukin-6-receptorsystem is activated in donor hearts
J. Am. Coll. Cardiol.,
May 1, 2002;
39(9):
1508 - 1512.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Adams, B. Nehrhoff, U. Spate, A. Linke, P. C Schulze, A. Baur, S. Gielen, R. Hambrecht, and G. Schuler
Induction of iNOS expression in skeletal muscle by IL-1{beta} and NF{kappa}B activation: an in vitro and in vivo study
Cardiovasc Res,
April 1, 2002;
54(1):
95 - 104.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. C. Colombo, A. W. Ashton, S. Celaj, A. Talreja, J. E. Banchs, N. B. Dubois, M. Marinaccio, S. Malla, J. Lachmann, J. A. Ware, et al.
Biopsy coupled to quantitative immunofluorescence: a new method to study the human vascular endothelium
J Appl Physiol,
March 1, 2002;
92(3):
1331 - 1338.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. S. Bradham, B. Bozkurt, H. Gunasinghe, D. Mann, and F. G. Spinale
Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective
Cardiovasc Res,
March 1, 2002;
53(4):
822 - 830.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Adamopoulos, J. Parissis, D. Karatzas, C. Kroupis, M. Georgiadis, G. Karavolias, J. Paraskevaidis, K. Koniavitou, A. J. S. Coats, and D. T. Kremastinos
Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fasligand system in patients with chronic heart failure
J. Am. Coll. Cardiol.,
February 20, 2002;
39(4):
653 - 663.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Hilfiker-Kleiner, A. Hilfiker, B. Schieffer, D. Engel, D. L Mann, K. C Wollert, and H. Drexler
TNF{alpha} decreases {alpha}MHC expression by a NO mediated pathway: role of E-box transcription factors for cardiomyocyte specific gene regulation
Cardiovasc Res,
February 1, 2002;
53(2):
460 - 469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Degousee, E. Stefanski, T. F. Lindsay, D. A. Ford, R. Shahani, C. A. Andrews, D. J. Thuerauf, C. C. Glembotski, T. J. Nevalainen, J. Tischfield, et al.
p38 MAPK Regulates Group IIa Phospholipase A2 Expression in Interleukin-1beta -stimulated Rat Neonatal Cardiomyocytes
J. Biol. Chem.,
November 16, 2001;
276(47):
43842 - 43849.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Aukrust, L. Gullestad, K. T. Lappegard, T. Ueland, H. Aass, L. Wikeby, S. Simonsen, S. S. Froland, and T. E. Mollnes
Complement Activation in Patients With Congestive Heart Failure: Effect of High-Dose Intravenous Immunoglobulin Treatment
Circulation,
September 25, 2001;
104(13):
1494 - 1500.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Triboulot, A. Hichami, A. Denys, and N. A. Khan
Dietary (n-3) Polyunsaturated Fatty Acids Exert Antihypertensive Effects by Modulating Calcium Signaling in T Cells of Rats
J. Nutr.,
September 1, 2001;
131(9):
2364 - 2369.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Y. T. Hart, E. L. Hahn, D. M. Meyer, J. C. Burnett Jr., and M. M. Redfield
Differential effects of natriuretic peptides and NO on LV function in heart failure and normal dogs
Am J Physiol Heart Circ Physiol,
July 1, 2001;
281(1):
H146 - H154.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. McIlroy, C. Troadec, F. Grassi, A. Samri, B. Barrou, B. Autran, P. Debre, J. Feuillard, and A. Hosmalin
Investigation of human spleen dendritic cell phenotype and distribution reveals evidence of in vivo activation in a subset of organ donors
Blood,
June 1, 2001;
97(11):
3470 - 3477.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Deswal, N. J. Petersen, A. M. Feldman, J. B. Young, B. G. White, and D. L. Mann
Cytokines and Cytokine Receptors in Advanced Heart Failure : An Analysis of the Cytokine Database from the Vesnarinone Trial (VEST)
Circulation,
April 24, 2001;
103(16):
2055 - 2059.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Gullestad, H. Aass, J. G. Fjeld, L. Wikeby, A. K. Andreassen, H. Ihlen, S. Simonsen, J. Kjekshus, S. Nitter-Hauge, T. Ueland, et al.
Immunomodulating Therapy With Intravenous Immunoglobulin in Patients With Chronic Heart Failure
Circulation,
January 16, 2001;
103(2):
220 - 225.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Rossig, J. Haendeler, Z. Mallat, B. Hugel, J.-M. Freyssinet, A. Tedgui, S. Dimmeler, and A. M. Zeiher
Congestive heart failure induces endothelial cell apoptosis: protective role of carvedilol
J. Am. Coll. Cardiol.,
December 1, 2000;
36(7):
2081 - 2089.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Bozkurt
Activation of cytokines as a mechanism of disease progression in heart failure
Ann Rheum Dis,
November 1, 2000;
59(90001):
i90 - 93.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Gierens, M. Nauck, M. Roth, R. Schinker, C. Schurmann, H. Scharnagl, G. Neuhaus, H. Wieland, and W. Marz
Interleukin-6 Stimulates LDL Receptor Gene Expression via Activation of Sterol-Responsive and Sp1 Binding Elements
Arterioscler. Thromb. Vasc. Biol.,
July 1, 2000;
20(7):
1777 - 1783.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Hamanaka, Y. Saito, T. Nishikimi, T. Magaribuchi, S. Kamitani, K. Kuwahara, M. Ishikawa, Y. Miyamoto, M. Harada, E. Ogawa, et al.
Effects of cardiotrophin-1 on hemodynamics and endocrine function of the heart
Am J Physiol Heart Circ Physiol,
July 1, 2000;
279(1):
H388 - H396.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Murray, S. D. Prabhu, and B. Chandrasekar
Chronic {beta}-Adrenergic Stimulation Induces Myocardial Proinflammatory Cytokine Expression
Circulation,
May 23, 2000;
101(20):
2338 - 2341.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Prabhu, B. Chandrasekar, D. R. Murray, and G. L. Freeman
{beta}-Adrenergic Blockade in Developing Heart Failure : Effects on Myocardial Inflammatory Cytokines, Nitric Oxide, and Remodeling
Circulation,
May 2, 2000;
101(17):
2103 - 2109.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Feldman, A. Combes, D. Wagner, T. Kadakomi, T. Kubota, Y. You Li, and C. McTiernan
The role of tumor necrosis factor in the pathophysiology of heart failure
J. Am. Coll. Cardiol.,
March 1, 2000;
35(3):
537 - 544.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. He and M. C. LaPointe
Interleukin-1{beta} Regulates the Human Brain Natriuretic Peptide Promoter via Ca2+-Dependent Protein Kinase Pathways
Hypertension,
January 1, 2000;
35(1):
292 - 296.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Gullestad, P.a. Aukrust, T. Ueland, T. Espevik, G. Yee, R. Vagelos, S. S. Froland, and M. Fowler
Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure
J. Am. Coll. Cardiol.,
December 1, 1999;
34(7):
2061 - 2067.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Wagner, T. Kubota, V. J. Sanders, C. F. McTiernan, and A. M. Feldman
Differential regulation of cardiac expression of IL-6 and TNF-alpha by A2- and A3-adenosine receptors
Am J Physiol Heart Circ Physiol,
June 1, 1999;
276(6):
H2141 - H2147.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Y. Li, C. F. McTiernan, and A. M. Feldman
Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells
Cardiovasc Res,
April 1, 1999;
42(1):
162 - 172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Franco, G. D. Thomas, B. Giroir, D. Bryant, M. C. Bullock, M. C. Chwialkowski, R. G. Victor, and R. M. Peshock
Magnetic Resonance Imaging and Invasive Evaluation of Development of Heart Failure in Transgenic Mice With Myocardial Expression of Tumor Necrosis Factor-{alpha}
Circulation,
January 26, 1999;
99(3):
448 - 454.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|